Kefir, Gut Microbiota, and Athletic Performance in Soccer Players
KEFIR-SPORT
Effects of Kefir Consumption on Gut Microbiota and Athletic Performance in Professional Female Soccer Players: a Randomized Controlled Trial
2 other identifiers
interventional
21
1 country
1
Brief Summary
This research work is a clinical trial that will assess the impact of kefir consumption on the gut microbiota profile and athletic performance of female soccer players of age 18-29 years. The participants were divided into two groups namely the kefir intervention group and the control group. The primary end points are the modifications in the alpha diversity of the gut microbiome and the beta diversity of the gut microbiome and also the athletic performance outcomes like VO2 max and finishing speed which will be measured using the 30-15 Intermittent Fitness Test. The other outcomes of the study are the changes in the body composition (measured through BIA and skinfold), the changes in the dietary intake and the variations in certain microbial genera such as Akkermansia muciniphila and Faecalibacterium prausnitzii. The study will be the first to evaluate whether kefir intake can increase the microbial diversity, increase the VO2max and improve the body composition of professional athletes. The anticipated outcomes of this study are enhanced gut microbial diversity, enhanced VO2max and finishing speed, and positive alteration in the body composition parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 20, 2024
CompletedFirst Posted
Study publicly available on registry
December 31, 2024
CompletedDecember 31, 2024
December 1, 2024
1 month
December 20, 2024
December 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Gut Microbiota Composition Change
Changes in gut microbiota diversity and abundance at genus and phylum levels, assessed through 16S rRNA gene sequencing of stool samples.
At baseline and after 4 weeks of intervention (Week 5)
Athletic Performance Improvement
Improvement in athletic performance as measured by the 30-15 Intermittent Fitness Test, evaluating VO2max and finishing speed.
At baseline and after 4 weeks of intervention (Week 5)
Secondary Outcomes (6)
Dietary Intake Assessment
At baseline and after 4 weeks of intervention (Week 5)
Body weight (kg)
At baseline and after 4 weeks of intervention (Week 5)
Body Fat Percentage (%)
At baseline and after 4 weeks of intervention (Week 5)
Fat mass (kg)
At baseline and after 4 weeks of intervention (Week 5)
Fat-free mass (kg)
At baseline and after 4 weeks of intervention (Week 5)
- +1 more secondary outcomes
Study Arms (2)
Kefir Consumption Group
EXPERIMENTALParticipants in this group will consume 200 ml of kefir daily for 4 weeks. Their diet will remain ad libitum, with no additional dietary restrictions or standardization applied during the intervention period. The primary intervention in our study is the daily consumption of kefir (200 ml/day). No additional drug or medical device was used during the intervention or data collection process. The study focused solely on kefir consumption and its effects on athletic performance and gut microbiota.
Control Group
NO INTERVENTIONParticipants in this group will not receive any specific intervention. They will continue their usual diet ad libitum, with no dietary restrictions or standardization applied during the study period.
Interventions
200 ml/day kefir The primary intervention in our study is the daily consumption of kefir (200 ml/day). No additional drug or medical device was used during the intervention or data collection process. The study focused solely on kefir consumption and its effects on athletic performance and gut microbiota.
Eligibility Criteria
You may qualify if:
- Professional female soccer player
- Aged between 18 and 35 years
- Regular participation in a structured training program
- No allergy or intolerance to kefir or dairy products
- Willingness to voluntarily participate in the study
- Signed informed consent form
You may not qualify if:
- History of allergy or intolerance to kefir or dairy products
- Presence of chronic diseases (e.g., diabetes, heart disease, kidney failure)
- Use of antibiotics or probiotic supplements within the last 3 months
- Pregnancy or breastfeeding
- Inability to comply with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Vatan Sports Club
Istanbul, Istanbul, 34091, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Duygu Sağlam, Associate Professor
Acibadem University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2024
First Posted
December 31, 2024
Study Start
May 1, 2024
Primary Completion
June 5, 2024
Study Completion
December 1, 2024
Last Updated
December 31, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- De-identified IPD and supporting documents (e.g., Study Protocol, SAP) will be available starting 6 months after publication of primary results and will remain available indefinitely
- Access Criteria
- Researchers with a methodologically sound research proposal, approved by an independent ethics committee, will be able to access de-identified individual participant data (IPD) and supporting documents (e.g., Study Protocol, SAP). Data will be shared through a secure online repository upon request. Access will be granted after signing a Data Use Agreement, ensuring data confidentiality and ethical use.
De-identified individual participant data from gut microbiota analysis, including genus and phylum-level diversity and abundance, assessed using 16S rRNA sequencing. De-identified performance test data, such as VO2max and finishing speed results from the 30-15 Intermittent Fitness Test. De-identified body composition data, including body fat percentage and lean muscle mass assessed using BIA and caliper measurements. De-identified dietary intake data collected through 3-day food records, including macronutrient and micronutrient consumption.